Ventolin (salbutamol sulphate) - Important Safety Information from GlaxoSmithKline (Ireland) Ltd as approved by the Irish Medicines Board

Notice type: 3rd Party Publications

Date: 07/10/2013

 

Problem Or Issue:
Important Safety Information communication from GlaxoSmithKline (Ireland) Ltd on important restrictions regarding the use of short-acting beta agonists (SABAs) in obstetric indications. 

Important Safety Information ­- Ventolin (salbutamol sulphate)


« Back